COVID-19

COVID-19 in 2025  

The unprecedented COVID-19 pandemic spanning over three years claimed millions of lives worldwide and caused immense misery to the humanity. Rapid developments of vaccines...

CoViNet: A New Network of Global Laboratories for Coronaviruses 

A new global network of laboratories for coronaviruses, CoViNet, has been launched by WHO. The aim behind this initiative is to bring together surveillance...

COVID-19: Severe lung infection affects heart through “cardiac macrophage shift” 

It is known that COVID-19 increases the risk of heart attack, stroke, and Long COVID but what was not known is whether the damage...

SARS-CoV-2: How Serious is B.1.1.529 variant, now named Omicron

The B.1.1.529 variant was first reported to WHO from South Africa on 24th November 2021. The first known confirmed B.1.1.529 infection was from a specimen...

B.1.1.529 variant named Omicron, designated as a Variant of concern (VOC) by WHO

WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) was convened on 26th November 2021 to assess the variant B.1.1.529. Based on the available evidences,...

COVID-19 Wave in the Europe: Current Situation and Projections for this Winter in UK, Germany, USA and India

Europe is reeling with an unusually high number of COVID 19 cases for the past few weeks and this can be attributed to the...

COVID-19 Situation across Europe is Very Serious

COVID-19 situation across Europe and central Asia is very serious. According to WHO, Europe could face over 2 million COVID-19 deaths by March 2022. Wearing...

“Pan-coronavirus” vaccines: RNA Polymerase Emerges as a Vaccine Target

Resistance to COVID-19 infection has been observed in health care workers and has been attributed to the presence of memory T cells that target...

Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Molnupiravir, the world’s first oral drug (approved by MHRA, UK) against COVID-19 along with upcoming drugs such as Paxlovid and sustained vaccination drive has raised hopes...

Fluvoxamine: Anti-depressant can Prevent Hospitalisation and COVID death

Fluvoxamine is an inexpensive anti-depressant commonly used in mental healthcare. Evidence from the recently concluded clinical trial suggest that it can be repurposed to treat...

Variants of Coronavirus: What We Know So Far

Coronaviruses are RNA viruses belonging to coronaviridae family. These viruses display remarkably high rates of errors during replication due to lack of proofreading nuclease activity of their polymerases....

Stay in touch:

88,881FansLike
45,363FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Dark Matter in the Centre of our Home Galaxy 

Fermi telescope made clean observation of excess γ-ray emission...

Lead Poisoning in Food from certain Aluminium and Brass Cookware 

Test result has shown that certain aluminum and brass...